An ultrasound probe emits sound waves that penetrate the body. Because organs and tissues have different physical properties, they reflect the waves differently. The device analyses these “echoes” and reconstructs a three-dimensional image of the inside of the body called an “echograph”, or more commonly, ultrasound.
Usually, the device measures the intensity of the reflected sound waves. But a team from the Swiss Federal Institute of Technology ETH Zurich also studied the echo duration, which allowed them to produce images with enhanced contrast that are useful for cancer diagnosis. The researchers were thus able to detect the presence of tumours and distinguish benign tumours from malignant ones.
The density and rigidity of body tissues determines the speed of the sound echo. Tumours are more rigid than the surrounding tissue, especially when they are cancerous. As a result, sound travels 3% faster on average in malignant tissues than in healthy tissues, and 1.5% faster than in benign tumours.
During clinical trials, which are ongoing, the Zurich team demonstrated the effectiveness of their prototype in detecting breast tumours.
“Our goal is to provide physicians with a better tool for decision-making during routine checks, and to avoid unnecessary biopsies,” said Orçun Göksel, assistant professor at ETH Zurich and director of the study. “Compared with conventional ultrasound, our images are much easier to interpret.”
Swiss invention: 90-year anniversary of first T-bar ski lift
This content was published on
On Monday it will be 90 years since the world’s first T-bar ski lift went into service in Davos. This Swiss invention was an instant success.
Iran summons Swiss ambassador over US and Italy arrests
This content was published on
Iran has summoned the Swiss ambassador, who represents US interests, to protest against the arrest in the US and Italy of two Iranians.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Cancer expected to kill 18,000 Swiss this year
This content was published on
More than 56,000 new cases of cancer will be diagnosed in Switzerland in 2018, says a report released by the World Health Organization (WHO).
This content was published on
“You can do what you like, just don’t pull your breast out of the water,” as Serafino Forte tells his patient at Basel University Hospital’s breast centre. She’s lying belly down on a table with a round hole cut into it; her right breast is hanging into the basin below. Under the surface, ultrasonic sensors…
Swiss hospitals join forces in battle against cancer
This content was published on
Fribourg's cantonal hospital is joining forces with a private clinic to tackle prostate and breast cancers. It's a first in Switzerland.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.